Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
FDA approvals
Pharma
FDA approves Otsuka’s first-in-class ADHD drug Simtriyo
How the DEA classifies Simtriyo could determine its commercial potential in a crowded ADHD market.
Angus Liu
Jul 27, 2026 12:42pm
Nuvalent deal delivers GSK’s first-ever lung cancer approval
Jul 22, 2026 3:15pm
Vera’s dual-target atacicept wins FDA approval for IgAN
Jul 7, 2026 12:23pm
Orca Bio takes commercial leap with FDA approval for Tregzi
Jul 1, 2026 12:14am
AZ, Daiichi's Datroway approved in first-line TNBC
May 22, 2026 11:32am
Enhertu secures dual FDA approvals in early breast cancer
May 18, 2026 10:52am